Clinical Data Pfizer, BioNTech Halt Large US COVID-19 Vaccine Trial Over Slow Enrollment BioSpaceCOVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data.Clinical DataInfectious DiseaseRead full story pharminent April 2, 2026 (Last updated: April 2, 2026) BioSpace COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver relevant post-marketing data. Clinical DataInfectious DiseaseRead full story Post navigation Previous: AZ claims another win for Imfinzi in frontline liver cancerNext: Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling Related Stories Clinical Data BridgeBio stands up to Pfizer in ATTR-CM as late-stage data hint at better survival pharminent May 12, 2026 Clinical Data Novo says high-dose Wegovy can cause 28% weight loss pharminent May 12, 2026 Clinical Data Pulsesight reports positive phase 1 data for PST611 in dry AMD pharminent May 11, 2026
